Immediate Impact
56 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Interstitial Lung Disease
2024 Standout
Works of Christopher A. Roberts being referenced
A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christopher A. Roberts | 297 | 334 | 216 | 439 | 403 | 35 | 1.3k | |
| Alexander S. Mark | 341 | 238 | 182 | 195 | 149 | 36 | 1.2k | |
| Yitzhak Marmary | 272 | 139 | 166 | 117 | 172 | 59 | 1.6k | |
| Dennis T. Lanigan | 535 | 120 | 80 | 151 | 138 | 23 | 1.2k | |
| W.A.M. van der Kwast | 304 | 351 | 267 | 120 | 124 | 30 | 1.1k | |
| Peter D. Quinn | 345 | 302 | 259 | 86 | 157 | 60 | 1.0k | |
| Piero Cascone | 452 | 337 | 258 | 95 | 164 | 124 | 1.3k | |
| Sheldon Mintz | 254 | 66 | 296 | 107 | 129 | 66 | 1.0k | |
| Rudolf H. Reich | 409 | 207 | 174 | 71 | 86 | 58 | 1.1k | |
| Michael T. Montgomery | 144 | 229 | 154 | 48 | 165 | 39 | 1.1k | |
| Daniel E. Waite | 325 | 211 | 188 | 141 | 148 | 51 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...